Pilocarpine (Salagen) oral formulation is used in the treatment of patients with dry mouth secondary to radiation of the head and neck. It may also be used in patients with Sjogren's syndrome.
Pilocarpine Uses:
- Xerostomia:
- It is used for the symptomatic treatment of dry mouth that occurs due to salivary gland dysfunction in patients undergoing radiotherapy of the head and neck region.
- It may be used for dry mouth in patients with Sjogren's syndrome.
Pilocarpine Dose in Adults
Dose in the treatment of Xerostomia: Oral:
- Associated with head and neck cancer:
- Initial: 5 mg three times a day.
- The dose may be treated based on the clinical response and tolerability.
- The usual dosage range is 15 to 30 mg per day;
- The maximum dose is 10 mg/dose.
- Sjögren syndrome:
- 5 mg four times a day.
Use in Children:
Not indicated.
Pregnancy Category: C
- The drug was not evaluated in animal reproduction studies.
Pilocarpine use during breastfeeding:
- It is unknown if the drug will be excreted into breast milk.
- The manufacturer suggests that infants are evaluated for side effects and to weigh the benefits of treatment in comparison to the risks.
Dose in Kidney Disease:
There are no dosage adjustments provided in the manufacturer’s labeling.
Dose in Liver disease:
- Mild impairment (Child-Pugh score 5 to 6):
- Adjustment in the dose is not necessary.
- Moderate impairment (Child-Pugh score 7 to 9):
- Initial dose: 5 mg two times a day
- Adjust the dose based on the patients' response and tolerance.
- Severe impairment (Child-Pugh score 10 to 15):
- It is not recommended in patients with severe liver disease.
Common Side Effects of Pilocarpine:
- Cardiovascular:
- Flushing
- Central Nervous System:
- Chills
- Dizziness
- Headache
- Gastrointestinal:
- Nausea
- Genitourinary:
- Urinary Frequency
- Neuromuscular & Skeletal:
- Weakness
- Respiratory:
- Rhinitis
- Miscellaneous:
- Diaphoresis
Less Common Side Effects Of Pilocarpine:
- Cardiovascular:
- Edema
- Facial Edema
- Hypertension
- Palpitation
- Tachycardia
- Central Nervous System:
- Pain
- Fever
- Somnolence
- Dermatologic:
- Pruritus
- Rash
- Gastrointestinal:
- Diarrhea
- Dyspepsia
- Vomiting
- Constipation
- Flatulence
- Glossitis
- Salivation Increased
- Stomatitis
- Taste Perversion
- Genitourinary:
- Vaginitis
- Urinary Incontinence
- Neuromuscular & Skeletal:
- Myalgias
- Tremor
- Ocular:
- Lacrimation
- Amblyopia
- Abnormal Vision
- Blurred Vision
- Conjunctivitis
- Otic:
- Tinnitus
- Respiratory:
- Cough Increased
- Dysphagia
- Epistaxis
- Sinusitis
- Miscellaneous:
- Allergic Reaction
- Voice Alteration
Contraindications to Pilocarpine:
- Hypersensitivity to pilocarpine and any component of the formulation
- Uncontrolled asthma
- It is not recommended for patients with acute iritis and angle-closure eye glaucoma.
Warnings and precautions
- Cardiovascular disease
- Patients suffering from cardiovascular disease should be cautious when using it, as they might experience a transient rhythm and/or hemodynamic changes.
- Cholelithiasis
- Patients suffering from biliary tract diseases or cholelithiasis should be cautious.
- Hepatic impairment
- Patients with advanced or severe liver disease should not use it.
- Moderate hepatic impairment may require a reduction of the dose. This should be avoided and used with caution.
- Nephrolithiasis
- Smooth muscle spasms may occur. Patients with kidney stones should be cautious about using the drug as it can cause a urteral reflux and precipitate renal colic.
- Respiratory problems
- Pilocarpine can increase bronchial smooth muscles tone and secretions. It also increases resistance to airway obstruction.
- Patients with chronic bronchitis, asthma, or chronic obstructive lung disease should not use it.
Pilocarpine (systemic): Drug Interaction
|
Acetylcholinesterase Inhibitors |
May enhance the adverse/toxic effect of Cholinergic Agonists. |
|
Beta-Blockers |
May enhance the adverse/toxic effect of Cholinergic Agonists. Of particular concern are the potential for cardiac conduction abnormalities and bronchoconstriction. Management: Administer these agents in combination with caution, and monitor for conduction disturbances. Avoid methacholine with any beta blocker due to the potential for additive bronchoconstriction. |
|
Cimetropium |
Cholinergic Agonists may diminish the anticholinergic effect of Cimetropium. |
|
Sincalide |
Drugs that Affect Gallbladder Function may diminish the therapeutic effect of Sincalide. Management: Consider discontinuing drugs that may affect gallbladder motility prior to the use of sincalide to stimulate gallbladder contraction. |
Monitoring Parameters:
Monitor ECG and the response to therapy.
How to administer Pilocarpine?
- It should not be administered with a high-fat meal.
- Patients must be advised to take plenty of water to avoid dehydration.
Mechanism of action of Pilocarpine:
It increases salivary gland secretion, such as sweat and salivary cells, and increases the tone and flexibility of the urinary tract.
The beginning of action:
- 20 minutes;
- Maximum effect: 1 hour
Duration:
- 3 to 5 hours
Half-life elimination:
- 0.76 to 1.35 hours;
- mild to moderate hepatic impairment: 2.1 hours
Time to peak, serum:
- 0.85 to 1.25 hours (increased to 1.47 hours with a high-fat meal)
Excretion:
- Urine
International Brands of Pilocarpine:
- Salagen
Pilocarpine Brand Names in Pakistan:
Pilocarpine HCl, Nitrate Eye Drops 2 %w/v |
|
|
Medicarpine |
Medipak Limited |
|
Opta Carpine |
Remington Pharmaceutical Industries (Pvt) Ltd. |
|
Orbacarpine |
Zafa Pharmaceutical Laboratories (Pvt) Ltd. |
|
Pilocar |
Ethical Laboratories (Pvt) Ltd. |
|
Pilocar |
Ethical Laboratories (Pvt) Ltd. |
|
Spersacarpine |
Novartis Pharma (Pak) Ltd |
Pilocarpine HCl, Nitrate Eye Drops 4 %w/v |
|
|
Medicarpine |
Medipak Limited |
|
Opta Carpine |
Remington Pharmaceutical Industries (Pvt) Ltd. |
|
Pilocar |
Ethical Laboratories (Pvt) Ltd. |
|
Pilocar |
Ethical Laboratories (Pvt) Ltd. |